In this interview with Triangle Business Journal, CEO Peyton Howell shares her vision for how Parexel will tackle global challenges and leverage cutting-edge technology to reach more patients where they are. Read it: https://lnkd.in/dHGsTnsd #PatientsFirst
Naomi Angelotti’s Post
More Relevant Posts
-
In this interview with Triangle Business Journal, CEO Peyton Howell shares her vision for how Parexel will tackle global challenges and leverage cutting-edge technology to reach more patients where they are. Read it: https://lnkd.in/dHGsTnsd #PatientsFirst
She takes the reins at 21,000-employee firm - Triangle Business Journal
share.parexel.social
To view or add a comment, sign in
-
In this interview with Triangle Business Journal, CEO Peyton Howell shares her vision for how Parexel will tackle global challenges and leverage cutting-edge technology to reach more patients where they are. Read it: https://lnkd.in/ecZe2vbc #PatientsFirst
She takes the reins at 21,000-employee firm - Triangle Business Journal
share.parexel.social
To view or add a comment, sign in
-
In this interview with Triangle Business Journal, CEO Peyton Howell shares her vision for how Parexel will tackle global challenges and leverage cutting-edge technology to reach more patients where they are. Read it: https://lnkd.in/esy_aHGe #PatientsFirst
She takes the reins at 21,000-employee firm - Triangle Business Journal
share.parexel.social
To view or add a comment, sign in
-
In this interview with Triangle Business Journal, CEO Peyton Howell shares her vision for how Parexel will tackle global challenges and leverage cutting-edge technology to reach more patients where they are. Read it: https://lnkd.in/eQ_y7yzK #PatientsFirst
She takes the reins at 21,000-employee firm - Triangle Business Journal
share.parexel.social
To view or add a comment, sign in
-
In this interview with Triangle Business Journal, CEO Peyton Howell shares her vision for how Parexel will tackle global challenges and leverage cutting-edge technology to reach more patients where they are. Read it: https://lnkd.in/dHGsTnsd #PatientsFirst
She takes the reins at 21,000-employee firm - Triangle Business Journal
share.parexel.social
To view or add a comment, sign in
-
In this interview with Triangle Business Journal, CEO Peyton Howell shares her vision for how Parexel will tackle global challenges and leverage cutting-edge technology to reach more patients where they are. Read it: https://lnkd.in/dHGsTnsd #PatientsFirst
She takes the reins at 21,000-employee firm - Triangle Business Journal
share.parexel.social
To view or add a comment, sign in
-
In this interview with Triangle Business Journal, CEO Peyton Howell shares her vision for how Parexel will tackle global challenges and leverage cutting-edge technology to reach more patients where they are. Read it: https://lnkd.in/dHGsTnsd #PatientsFirst
She takes the reins at 21,000-employee firm - Triangle Business Journal
share.parexel.social
To view or add a comment, sign in
-
In this interview with Triangle Business Journal, CEO Peyton Howell shares her vision for how Parexel will tackle global challenges and leverage cutting-edge technology to reach more patients where they are. Read it: https://lnkd.in/dHGsTnsd #PatientsFirst
She takes the reins at 21,000-employee firm - Triangle Business Journal
share.parexel.social
To view or add a comment, sign in
-
In this interview with Triangle Business Journal, CEO Peyton Howell shares her vision for how Parexel will tackle global challenges and leverage cutting-edge technology to reach more patients where they are. Read it: https://lnkd.in/eYh6PRSY #PatientsFirst
She takes the reins at 21,000-employee firm - Triangle Business Journal
share.parexel.social
To view or add a comment, sign in
-
In this interview with Triangle Business Journal, CEO Peyton Howell shares her vision for how Parexel will tackle global challenges and leverage cutting-edge technology to reach more patients where they are. Read it: https://lnkd.in/g4zPuR-J #PatientsFirst
She takes the reins at 21,000-employee firm - Triangle Business Journal
share.parexel.social
To view or add a comment, sign in